January 18th in Drugs by Vivian Goldschmidt, MA .
A new study by the University of Massachusetts Medical School has found that women in their 50’s, 60’s and 70’s who took statins to lower cholesterol had a 48 percent greater chance of becoming diabetic than women who did not take the statin drugs.1
And as you’ll read in today’s alert, …
October 27th in Drugs by Vivian Goldschmidt, MA .
Just one week ago, I posted an article on new discoveries about the immune system and how they help explain the inefficacy of the flu shot. Not surprisingly, it stirred up some controversy, and many in our community voiced their opinions loud and clear.
I, for one, was not surprised. …
October 17th in Drugs by Vivian Goldschmidt, MA .
They’re almost impossible to ignore. From storefronts to highways, you’ve probably seen the imposing signs and billboards proclaiming “Flu Shots Now Availalbe.” But in reality, there’s nothing new about these vaccines, because this year’s flu shot happens to be identical to the one formulated for last year’s flu season. …
October 5th in Drugs by Vivian Goldschmidt, MA .
As it relates to osteoporosis news, this past September will be one to remember. In response to a growing number of reported adverse effects linked to bisphosphonates – the most commonly prescribed osteoporosis drugs such as Fosamax, Actonel, and Boniva, to name a few – an FDA advisory …
September 22nd in Drugs by Vivian Goldschmidt, MA .
They say that numbers don’t lie. So when statistics clearly show that for the first time ever in the U.S.A. prescription drugs have killed more people than car accidents, even the CDC is forced to face the sad truth.
The numbers reported just a couple of days ago by ABC …
September 5th in Drugs by Vivian Goldschmidt, MA .
As I write in a recent blog post titled ‘Alert: New Life-Threatening Reclast Side Effects’, the most commonly reported Reclast side effects – ranging from joint and bone pain to osteonecrosis of the jaw – pale in comparison to the most recent concerns regarding kidney impairment and failure.
In the …
March 30th in Drugs by Vivian Goldschmidt, MA .
Acid reflux drugs increase risk of fractures. Such is the title of an article published just a few days ago. Considered as “breakthrough” news, I have been warning of the very same problem in the Save Our Bones Program for years.
This is just further evidence of how the Save Our …
March 13th in Drugs by Vivian Goldschmidt, MA .
US consumer advocacy groups are up in arms. New and devastating Reclast side effects led these groups to demand that new warnings be placed on the drug’s label.
As I wrote in my Reclast review, the most commonly reported Reclast side effects are fever, muscle, joint and bone pain, flu-like …
March 9th in Drugs by Vivian Goldschmidt, MA .
Atelvia (risedronate sodium), an oral bisphophonate made by Warner Chilcott, has been approved in the US on October 8, 2010. Here’s the simple trick used for creating Atelvia: clever marketing sleight of hand.
Let me explain.
Atelvia’s active ingredient is identical to its twin Actonel, and similar to its cousins Fosamax …
February 6th in Drugs by Vivian Goldschmidt, MA .
Let’s face it. When news breaks of an osteoporosis drug discovery that increases bone strength and reduces fractures in the hip, spine, wrist, leg, and rib, the medical establishment listens… and prescribes.
Add to this the convenience of a once-yearly 15 minute intravenous infusion, and it seems like an osteoporosis treatment …